GLP1R and type 2 diabetes mellitus: The glucose-lowering effect of bile acids is believed to be mediated by the GLP-1 receptor, as evidenced by the inhibition of this effect in T2D patients treated with a GLP-1 receptor antagonist (Sansome et al., 2020).